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Abstract
Background: Serodiagnosis of typhoid fever by Widal test based on demonstrating the presence of agglutinins
(antibodies) in the serum of an infected patient, against the H (flagellar) and O (somatic) antigens of Salmonella
enterica serotype Typhi has been associated with many debates. This is why the aim of this study was to: (i)
Compare the diagnostic accuracy of four different commercial kits used to perform Widal test (Remel, BioSystems,
Dialab and Biotec). (ii) Compare the sensitivity and specificity of both anti-O and anti-H antibodies. (iii) Compare
the validity of single versus paired serum samples with a rising titer for the diagnosis of typhoid fever.
Methods: Duplicate serum samples were obtained from150 patients clinically diagnosed as typhoid fever patients.
Moreover, single serum samples were obtained from 25 patients with febrile diseases other than typhoid fever. All
samples were tested using the four different Widal brands and Salmonella Typhi IgM anti-LPS ELISA
Results: -The results of Widal tests differed markedly using the four Widal brands in terms of sensitivity and
specificity at three cut-off values of 1/80, 1/160 and 1/320. Remel brand gave the highest sensitivities and the
lowest specificities and Dialab brand gave the highest specificities and the lowest sensitivities for both anti-O and
anti-H antibodies at the three cut-off values.
-Four fold rise in the antibodies titer was not demonstrable among clinically diagnosed typhoid fever patients
-H agglutinins were less sensitive and less specific than O agglutinins
Conclusions: -Widal test results showed marked discrepancies using different Widal brands. None of the serum
samples of the typhoid fever patients showed four fold rise in the antibody titers. Raised O agglutinins were of
slightly greater diagnostic value than raised H agglutinins.
Significance and impact of study: Widal test done sequentially using two brands could be of value in typhoid
fever diagnosis. Single serum sample could be used for typhoid fever diagnosis relying on anti O titer.
Introduction
Typhoid fever, one of the enteric diseases, is endemic in
Egypt [1]. Population-based studies indicated that typhoid
fever incidence is 10-100/100,000 per year, with an annual
peak in August [1]. An incidence of 13/100,000 persons
per year was estimated in a household survey conducted
in Belbis district in 2003 [2], while an incidence of
61/100,000 persons per year was estimated in Fayoum in
2002 [3].
The diagnosis of typhoid fever on clinical grounds is
difficult, as the presenting symptoms are diverse and
similar to those observed with other febrile illnesses [4].
Serodiagnosis of typhoid fever has been attempted
since the late nineteenth century by Widal and Secard
[5]. The test was based on demonstrating the presence of
agglutinins (antibodies) in the serum of an infected
patient, against the H (flagellar) and O (somatic) antigens
of Salmonella enterica serotype Typhi (S.T y p h i ) .W h i l e
the definitive diagnosis of typhoid fever depends on the
isolation of S. Typhi from blood, stools, urine or other
body fluids [6,7], the role of the Widal test has been to
increase the index of suspicion for the presence of
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during the acute and convalescent period of infection
with evidence of four fold rise in antibody titer [8-10].
Over 100 years since its introduction as a serologic
means of detecting the presence of typhoid fever, the
Widal test continues to be plagued with controversies
involving the quality of the antigens used and interpreta-
tion of the result, particularly in endemic areas [11].
Hoffman et al. stated that the results of single Widal
test, tube dilution or slide agglutination test are virtually
un-interpretable unless the sensitivity and specificity of
the test for the specific laboratory and patient population
are known [12]. Olopenia and King stated that the value
of Widal test depends upon the standardization and
maintenance of the antigens to produce consistent
results. They also mentioned that even since 1936 when
Welch stated that no Widal test, regardless of the com-
position and standardization of the antigens used is
infallible, and thus it is unlikely that any will be devel-
oped that will lower the validity of the isolation of the
etiologic agent. Unfortunately, more than 70 years after
Welch published his paper, the problems of insensitivity
and non-specificity of Widal antigens continue [11].
Many authors stated that the recommended definitive
interpretation of the Widal test is four fold rise in agglu-
tinins in sera taken 7 to 10 days apart [8,13]. Four folds
increase is not always demonstrable even in blood cul-
ture-confirmed cases [11,14,15].
Regarding O-agglutinin and H-agglutinin titer, Huck-
step have claimed that the level of H agglutinins is
unhelpful in the diagnosis of typhoid, maintaining that
the H-agglutinin titer remains elevated for a longer per-
iod than the O-agglutinin titer after an episode of typhoid
fever and also may rise as a nonspecific response to other
infections [16]. However Brodie, Coovadia, Pang and
Sommerville have proposed that the H-agglutinin titer is
as useful as or more useful than the O-agglutinin titer
[9,17-19]. While Parry stated that H agglutinins were less
sensitive but more specific than O agglutinins and
yielded better positive predictive values [20].
Hence the specific purpose of this study was to find a
clue to some of these debates concerning Widal test.
Subjects and methods
After obtaining the approval of the ethical committee of
the Egyptian Ministry of Health. Patients and controls at
the inpatient ward of Desouk fever hospital, kafr El-
Shekh governorate, Egypt, have been invited to partici-
pate in this research. Those who accepted were recruited
after obtaining their (or their parents) consents.
Typhoid fever patients group
This group included 150 patients, 85 males and 65
females, with age ranging from 4 years to 65 years
(mean age of 27.6 ± 23.33 years). They were clinically
suspected of typhoid fever (suffering from continuous
fever greater than 38°C in addition to headache, consti-
pation or diarrhea).
Hospital control group
This group included 25 patients (15 males and 10 females
with mean age of 31.68 ± 19 years) with febrile diseases
other than typhoid fever that have been diagnosed after
both clinical examination and laboratory investigation.
They included 12 patients with urinary tract infection,
5 patients with chest infection, 4 patients with brucellosis
and 4 patients with measles.
Samples collection
Paired blood samples were collected from typhoid fever
patients group (300 samples). The first blood sample
was obtained from 2 to 10 days from appearance of
symptoms while the second sample was obtained one
week interval from the first one. A single blood sample
was collected from patients in the hospital control
group (25 samples). Blood samples were centrifuged and
sera were separated and stored at -20°C.
Tests carried out
- Widal test
Widal test was performed on both first and second
serum samples using the following 4 commercially avail-
able brands:
A) Remel: Remel stained Salmonella Oa n dHs u s -
pensions, Remel Europe ltd, UK
B) BioSystems: Febrile serodiagnostic agglutination
slides and tubes, Biosystems S A, Barcelona, Spain
C) Dialab: Bacterial agglutination test, Dialab,
Austria
D) Biotec: Stained bacterial antigen suspensions,
Biotec, UK
Reagents in kits
Vials of 5 ml which contain standardized stained
smooth Salmonella suspensions of killed bacteria which
have been stained to facilitate readings of agglutination
tests. These bacterial antigens were: Salmonella Typhi
O, Salmonella Typhi H, Salmonella Paratyphi A-H and
Salmonella Paratyphi B-H.
Test procedure
All samples were first screened by slide agglutination
technique, when proven to be positive, they were further
tested by tube agglutination technique.
Slide agglutination technique
- Fifty microliters of undiluted serum were placed in a
3 cm diameter circle on a white tile
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shaken Widal suspension (both anti O and anti H) was
added using the dropper provided. In performing the
procedure using Remel brand, 20 microliters (instead of
50 microliters) of serum were used
- The contents were mixed by stirring for a few seconds
and spread to fill the whole area of a circle on the tile.
The tile was rotated slowly and agglutination was
observed for one minute.
- Clumping within one minute was considered posi-
tive. The reaction obtained was roughly equivalent to
this which would be obtained in a tube agglutination
test with serum dilution of 1/80.
Tube agglutination technique
- The patient’s sera were serially diluted (2 fold) in nor-
mal saline, starting by 1/80 to obtain dilutions of 1/80,
1/160, 1/320, 1/640, and 1/1280. One ml of each dilution
was dispensed in each of 8 tubes making two rows each
o f4t u b e s .F o rt h ef i r s tr o wo ft u b e sad r o po fa n t iO
antibodies (of each of the four used Widal brands) was
added, while to the second row of tubes a drop of anti H
antibodies (of each of the four used Widal brands) was
added. A tube containing 1 ml saline was included as a
negative control. All tubes were mixed, O suspensions
were incubated at 50°C for 4 hours and H suspensions
were incubated at 50°C for 2 hours. In a positive O reac-
tion, there was a granular agglutination; while H aggluti-
nation has a characteristic floccular appearance. In a
negative reaction and in the saline the appearance of the
suspension should be unchanged, and show a typical
swirl when the tube is flicked. The tubes were not sha-
ken. The titer in each case is the highest tube dilution of
the serum showing agglutination. Figure 1, 2
ELISA test (Salmonella Typhi IgM anti-LPS ELISA BIO-
QUANT INC, USA)
-In the present study detection of S. Typhi by culture
methods was not done, instead ELISA test was performed
as a comparative test to Widal on the first serum sample
of 91 randomly chosen patients of the 150 clinically diag-
nosed typhoid fever patients.
Assay procedure
The test was performed according to the manufacturer
instructions.
Statistical analysis
The data were collected and statistical analysis was
done. The statistical tests used namely sensitivity, speci-
ficity and accuracy. These were calculated by using the
following formulas: Sensitivity is a/(a + c), specificity is
d/(d + b), accuracy a+d/(a+b+c + d), where a is positive
E L I S Aa n dW i d a lt e s t ,b is Negative ELISA, but positive
Widal test, c is Positive ELISA, but negative Widal test,
and d is Negative ELISA, and negative Widal test [21].
Results
Of the 150 clinically diagnosed typhoid fever patients
included in the present study, 85 (56.7%) were males and
65 (43.3%) were females, with a mean age of 27.6 ± 23.33
years. The corresponding figures of the 25 hospital con-
trols were 15 (60%) males and 10 (40%) females with
mean age of 31.68 ± 19 years. The main presenting symp-
tom was fever among 149 (99.3%) cases and all (100%) the
25 hospital controls. The second main presenting symp-
tom was headache which was observed in 113 (75.3%)
cases and 12 (48%) hospital controls. Constipation was
more common among cases than diarrhea, it was observed
in 74 (49.3%) cases, while diarrhea was observed in 62
(41.3%) cases. Regarding antibiotics intake, 140 (93.3%) of
the 150 clinically diagnosed typhoid fever cases and 24
(96%) of the hospital controls received antibiotics before
hospitalization.
Regarding the antibody titer assay of the first serum
samples of the150 clinically diagnosed typhoid fever
cases by the four used Widal brands, marked discrepan-
cies were obtained. (Table 1)
Figure 1 Positive Widal test for anti-O antibodies.
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nesses other than typhoid, only one serum sample gave
positive Widal test result at a titer of 1/80 when using
each of Remel, Biosystems and Biotech brands, while
none of the samples reacted with Dialab brand at any
titer. It should be mentioned that in Egypt the Ministry
of Health and Population (MHP) consider a diagnostic
titer for typhoid fever to be of 1/160 for both anti O
and anti H antibodies.
Considering the difference in titers between the first
and second serum samples (one week interval) of
the150 clinically diagnosed typhoid fever cases none of
these samples showed a three or four fold increase upon
second testing for either anti-O and anti-H antibodies
by any of the used Widal brands.
For comparison of the sensitivity, specificity and accu-
racy of the 4 used Widal brands, IgM anti-LPS ELISA
test was performed as a reference test on the first serum
sample of 91 randomly chosen patients of the 150 clini-
cally diagnosed typhoid fever patients.
Table 2, 3, 4 shows the distribution of the results of
91 serum samples using the 4 Widal brands at a 1/80,
1/160 and1/320 cut-off values for anti-O antibodies in
relation to their corresponding IgM anti-LPS ELISA
results. Out of 91 serum samples tested by the ELISA
IgM anti-LPS antibodies, 67 samples (73.62%) showed
positive results. All these samples gave titers of ≥ 1/80
in the Widal test by using each of the Remel and Bio-
systems brands, while only 65 (97.01%) and 59 (88.05%)
samples showed these titers when using the Biotech and
Dialab brands respectively.
Table 5 shows the sensitivity, specificity and accuracy
of the 4 Widal brands for anti-O antibodies using cut-
off values of 1/80, 1/160 and 1/320 respectively using
IgM anti-LPS ELISA as a reference test.
Regarding the sensitivity of the 4 brands, it is clear
that, each of Remel and biosystems brands showed the
highest sensitivity compared to the other 2 used brands
at the 3 cut-off values. However the sensitivity of these
brands decreased by increasing the cut-off value it
Figure 2 Positive Widal test for anti-H antibodies.
Table 1 Antibody titers of the 150 clinically diagnosed typhoid fever cases in the first serum samples using 4 different
Widal brands
Widal
brand
Total No. of
positive samples (%)
No. of samples with given reciprocal titer
80 160 320 640 1280
O H O H OH OH OH O H
Remel 131
(87.34)
141
(94.00)
23 14 42 60 45 32 19 25 2 10
Biosystems 129
(86.00)
136
(90.66)
32 15 47 60 35 35 13 18 2 8
Biotech 125
(83.34)
129
(86.00)
28 25 59 55 30 25 8 20 0 4
Dialab 103
(68.67)
106
(70.66)
46 42 49 41 8 22 0 1 0 0
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at cut-off titer of 1/160 and to 59.7% at cut-off titer of
1/320 for Remel brand. The corresponding figures for
Biosystems brand were 100%, 83.58% and 46.26%
respectively.
Regarding the specificity, Dialab brand was the most
specific brand (91.66%) at the cut-off value of 1/80, how-
ever, at a cut-off value of 1/160 both Dialab and Biosys-
tems brand were the most specific brands (95.83% for
both brands). By increasing the cut-off value to 1/320,
the four brands showed the same specificity (100%).
The accuracy of the 4 used brands was almost the
same when using a cut-off of 1/80.
However Remel brand was the most accurate brand
using the cut-off values of 1/160 and 1/320 (87.91% and
70.23% respectively)
Tables 6, 7, 8 show the distribution of the results of
91 serum sample using the 4 Widal brands at a 1/80,
1/160 and 1/320 cut-off values for anti-H antibodies in
relation to their corresponding IgM anti-LPS ELISA
results. It was clear from this table, that none of the
used Widal brands could diagnose the 67 serum samples
diagnosed by ELISA for IgM antibodies. At 1/80, 1/160
and 1/320 cut-off values the highest sensitivity (94.02%,
83.58% and 56.71%) was obtained by Remel brand and
Table 2 Distribution of the results of 91 serum samples
using the 4 Widal brands for anti-O antibodies in
relation to their corresponding IgM anti-LPS ELISA
results using a cut-off 1/80
Widal
brand
anti -O
titer ≥ 1/80
ELISA (91) Total
Positive (67) Negative (24)
Number % Number %
Remel Negative 0 0.00 13 54.16 13
Positive 67 100.00 11 45.83 78
Biosystems Negative 0 0.00 14 58.33 14
Positive 67 100.00 10 41.66 77
Biotech Negative 2 2.98 14 58.33 16
Positive 65 97.01 10 41.66 75
Dialab Negative 8 11.94 22 91.66 30
Positive 59 88.05 2 8.33 61
Table 3 Distribution of the results of 91 serum samples
using the 4 Widal brands for anti-O antibodies in
relation to their corresponding IgM anti-LPS ELISA
results using a cut-off 1/160
Widal
brand
anti-O titer ≥
1/160
ELISA (91) Total
Positive (67) Negative (24)
Number % Number %
Remel (91) Negative 7 10.44 20 83.33 27
Positive 60 89.55 4 16.66 64
Biosystems
(91)
Negative 11 16.41 23 95.83 34
Positive 56 83.58 1 4.16 57
Biotech
(91)
Negative 13 19.4 20 83.33 33
Positive 54 80.59 4 16.66 58
Dialab (91) Negative 35 52.23 23 95.83 58
Positive 32 47.76 1 4.16 33
Table 4 Distribution of the results of 91 serum samples
using the 4 Widal brands for anti-O antibodies in
relation to their corresponding IgM anti-LPS ELISA
results using a cut-off 1/320
Widal
brand
anti-O titer ≥
1/320
ELISA (91) Total
Positive (67) Negative (24)
Number % Number %
Remel (91) Negative 27 40.29 24 100.00 51
Positive 40 59.7 0 0.00 40
Biosystems
(91)
Negative 36 53.73 24 100.00 60
Positive 31 46.26 0 0.00 31
Biotech
(91)
Negative 43 64.17 24 100.00 67
Positive 24 35.82 0 0.00 24
Dialab (91) Negative 65 97.01 24 100.00 89
Positive 2 2.98 0 0.00 2
Table 5 Sensitivity, specificity and accuracy of the 4
Widal brand for anti-O antibodies of 91 random serum
samples of the 150 clinically diagnosed typhoid fever
cases using IgM anti-LPS ELISA as a reference test at
three cut-off values
Using a cut-off 1/80
Brand sensitivity specificity accuracy
Remel 100.00% 54.16% 87.91%
Biosystems 100.00% 58.33% 89.01%
Biotech 97.00% 58.33% 86.81%
Dialab 88.10% 91.66% 89.01%
Using a cut-off 1/160
Remel 89.50% 83.33% 87.91%
Biosystems 83.58% 95.83% 86.81%
Biotech 80.59% 83.33% 81.31%
Dialab 47.76% 95.83% 60.40%
Using a cut-off1/320
Remel 59.70% 100.00% 70.32%
Biosystems 46.26% 100.00% 60.43%
Biotech 35.82% 100.00% 52.74%
Dialab 2.89% 100.00% 28.57%
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obtained by Dialab brand.
Table 9 shows sensitivity, specificity and accuracy of
the 4 Widal brands for anti-H antibodies using cut-off
values of 1/80, 1/160 and 1/320 respectively using IgM
anti-LPS ELISA as a reference test.
Regarding the sensitivity of the 4 brands, it is clear
that, Remel brand showed the highest percentages as
compared to the other 3 used brands at the 3 cut-off
values. However the sensitivity of this brand decreased
by increasing the cut-off value, it decreased from 94.02%
at 1/80, to 83.58% at 1/160 to 56.71% at 1/320.
Regarding the specificity, Dialab, brand was the most
specific brand at the 3 cut-off values. The accuracy of
the 4 used brands was almost the same when using a
cut-off of 1/160. However, Remel and Biosystems brands
w e r et h em o s ta c c u r a t eb r a n d su s i n gt h ec u t - o f fv a l u e s
of 1/80 (71.42% for both).
Discussion
Widal test has been used as an aid in the diagnosis of
typhoid fever for more than a century. Since this time
its value for the diagnosis of typhoid fever has been
debated [11]. The specific purpose of this study was to
find an answer to the following debates:
- Are different Widal brands from different manu-
facturers producing the same results?
Table 6 Distribution of the results of 91 serum samples
using the 4 Widal brands for anti-H antibodies in relation
to their corresponding IgM anti-LPS ELISA results using a
cut-off 1/80
Widal
brand
anti-H titer ≥
1/80
ELISA (91) Total
Positive (67) Negative (24)
Number % Number %
Remel Negative 4 5.97 2 8.33 6
Positive 63 94.02 22 91.66 85
Biosystems Negative 6 8.95 4 16.66 10
Positive 61 91.04 20 83.33 81
Biotech Negative 9 13.43 5 20.83 14
Positive 58 86.56 19 79.16 77
Dialab Negative 18 26.86 11 45.83 29
Positive 49 73.13 13 54.16 62
Table 7 Distribution of the results of 91 serum samples
using the 4 Widal brands for anti-H antibodies in relation
to their corresponding IgM anti-LPS ELISA results using a
cut-off 1/160
Widal
brand
anti-H titer ≥
1/160
ELISA (91) Total
Positive (67) Negative (24)
Number % Number %
Remel Negative 11 16.41 5 20.83 16
Positive 56 83.58 19 79.16 75
Biosystems Negative 13 19.4 7 29.16 20
Positive 54 80.59 17 70.83 71
Biotech Negative 18 26.86 13 54.16 31
Positive 49 73.13 11 45.83 60
Dialab Negative 30 44.77 22 91.66 52
Positive 37 55.22 2 8.33 39
Table 8 Distribution of the results of 91 serum samples
using the 4 Widal brands for anti-H antibodies in relation
to their corresponding IgM anti-LPS ELISA results using a
cut-off 1/320
Widal
brand
anti-H titer ≥
1/320
ELISA (91) Total
Positive (67) Negative (24)
Number % Number %
Remel Negative 29 43.28 19 79.16 48
Positive 38 56.71 5 20.83 43
Biosystems Negative 35 52.23 20 74.07 60
Positive 32 47.76 4 25.92 31
Biotech Negative 43 64.17 22 91.66 67
Positive 24 35.82 2 8.33 24
Dialab1) Negative 54 80.59 24 100.00 78
Positive 13 19.4 0 0.00 13
Table 9 Sensitivity, specificity and accuracy of the 4
Widal brand for anti-H antibodies of 91 random serum
samples of the 150 clinically diagnosed typhoid fever
cases using IgM anti-LPS ELISA as a reference test at
three cut-off values
Widal Brand sensitivity specificity accuracy
Using a cut-off 1/80
Remel 94.02% 8.33% 71.42%
Biosystems 91.04% 16.66% 71.42%
Biotech 86.56% 20.83% 69.23%
Dialab 73.13% 45.83% 65.93%
Using a cut-off 1/160
Remel 83.58% 20.83% 67.03%
Biosystems 80.59% 29.16% 67.03%
Biotech 73.13% 54.16% 68.13%
Dialab 55.22% 91.66% 64.83%
Using a cut-off 1/320
Remel 56.71% 79.16% 62.63%
Biosystems 47.76% 74.07% 57.14%
Biotech 35.82% 91.66% 50.54%
Dialab 19.40% 100.00% 40.65%
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-Which type of antibodies (either O or H) is
diagnostic?
-Is the test diagnostic by using a single serum sam-
ple or we should have paired sera to show a rising
antibodies titer?
In the present study marked discrepancies were obtained
when comparing the four used Widal brands at different
cut-off values. These discrepancies in results among differ-
ent brands are supported by Hoffman who stated that the
results of single Widal test, tube dilution or slide aggluti-
nation test are virtually un-interpretable unless the sensi-
tivity and specificity of the test for the specific laboratory
and patient population are known [12]. This is also sup-
ported by Olopoenia and King who stated that the value
of Widal test depends upon the standardization and main-
tenance of the antigens to produce consistent results [11].
Regarding the sensitivity and specificity of Widal test
the choice of a satisfactory gold standard for diagnosis is
crucial. Blood culture-positive patients as the confirmed
typhoid fever cases are the usually used gold standard
[19]. However, some patients with typhoid fever will be
blood culture negative, particularly in areas such as
Egypt, where antibiotic pretreatment is common [14,20].
Bone marrow culturing would be a better gold standard
[21], but this test is not routinely performed.
In the present study both blood and bone marrow cul-
tures were not feasible so we used IgM anti lipopolysac-
charide ELISA as our reference test against which we
compared the sensitivity and specificity of the used
tests. Naediello et al. used IgM anti-LPS ELISA for diag-
nosis of typhoid where they mentioned that when both
sensitivity and specificity were considered, the IgM anti-
LPS test gave the best discrimination between typhoid
patients and controls [22]. Also House et al. mentioned
that the anti-LPS IgM ELISA was more sensitive than
the Widal TO test in detecting culture confirmed
typhoid cases [23].
In this study O and H agglutinins were present at a titer
of 1/80 in one of the febrile hospital control groups by
three of the four used Widal brands (Remel, Biosystems
and Biotech) while none showed agglutinins with Dialab
brand. It should be mentioned that according to the Egyp-
tian Ministry of Health and Population (MHP) only a posi-
tive Widal titer of 1/160 for anti-O and or anti-H
antibodies could be considered as a probable typhoid case,
concomitant with compatible signs and symptoms of the
disease [15]. So if we followed this criterion none of the 25
hospital control groups clinically diagnosed as non typhoid
patients will be considered a typhoid positive case.
In this study the sensitivity and specificity of the four
used Widal brands at the cut-off value of 1/160
determined by the Egyptian MHP, for both anti-O and
anti-H antibodies were compared.
Regarding anti-O antibodies, Remel brand showed the
highest sensitivity and accuracy of, 89.50% and 87.91%
respectively, while Biosystem and Dialab brands showed
the highest specificity (95.38%) each.
Regarding anti-H antibodies, Remel brand also showed
the highest sensitivity of 83.58% but with decreased
accuracy of 67.03%, while Dialab brand still showing the
highest specificity of 91.66%.
More over, from the results of this study we were able
to conclude that Remel brand gave the highest sensitiv-
ities and Dialab brand gave the highest specificities for
anti-O and anti-H antibodies at the different 3 cut-off
values of 1/80, 1/160 and 1/320. Indeed, the Dialab was
the only brand that did not react non-specifically with
the 25 sera of the control febrile cases.
Huckstep have claimed that the level of H agglutinins is
unhelpful in the diagnosis of typhoid, maintaining that
the H-agglutinin titer remains elevated for a longer per-
iod than the O-agglutinin titer after an episode of typhoid
fever and also may rise as a nonspecific response to other
infections [16]. However Brodie, Coovadia, Pang and
Sommerville have proposed that the H-agglutinin titer is
as useful as or more useful than the O-agglutinin titer
[9,17-19]. While Parry stated that H agglutinins were less
sensitive but more specific than O agglutinins and
yielded better positive predictive values [20].
In this study, at the diagnostic Egyptian MHP titer of
1/160, H agglutinins were less sensitive (by all brands
except Dialab) and less specific (by all brands) than O
agglutinins and that a raised O agglutinins was of slightly
greater diagnostic value than a raised H agglutinins.
Many authors stated that the recommended definitive
interpretation of the Widal test is a four fold rise in
agglutinins in sera taken 7 to 10 days apart [8,24]. None
of the cases in this study showed three or four fold
increase in the antibodies titer using the four Widal
brands, and one or two fold increase was the common
finding. This finding is supported by Hassanien et al.
who stated that four fold rise, in the Widal antibody
titer is uncommon and two fold rise is the common
finding [25]. Satma et al. stated that four fold antibody
rise is rarely demonstrated and two-to three-fold rises
are more commonly seen [26]. A four fold increase is
not always demonstrable even in blood culture-
confirmed cases. This situation may occur due to many
reasons; the early treatment of cases of typhoid fever
with antibiotics, lack of antibody response in immuno-
suppressed patients, the delay in obtaining acute-phase
sample in the natural history of the disease and finally
the presence of high levels of background antibodies in
a region of endemicity [11,15].
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- An effort must be done to establish a protocol for
the standardization of the different commercially
available Widal brands to ensure consistent results
by different brands.
- Till the achievement of this standardization, we
recommend the dual use of two Widal brands to
improve the sensitivity and specificity of the test,
f i r s tb ys c r e e n i n gs e r aw i t hah i g h l ys e n s i t i v eb r a n d
and second by tracing false positive cases by testing
positive sera in the first testing by a highly specific
brand.
- If only one brand is to be used, the cut-off value of
this brand must be determined to the community
population.
- We recommend the use of acute phase sera using
Widal test to diagnose typhoid fever cases and not
rely on a 4 fold increase in the antibodies titer using
paired sera.
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